An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

United States

University of Colorado Hospital, Aurora, Colorado

Northwestern Memorial Hospital, Chicago, Illinois

University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania

UPMC Magee-Women's Hospital, Pittsburgh, Pennsylvania

University of Wisconsin - Carbone Cancer Center - University Hospital, Madison, Wisconsin